-+ 0.00%
-+ 0.00%
-+ 0.00%

Xeris Biopharma Holdings Raises FY2026 Sales Guidance from $375.000M-$390.000M to $380.000M-$390.000M vs $383.864M Est

Benzinga·05/07/2026 11:11:10
Listen to the news
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2026 sales outlook from $375.000 million-$390.000 million to $380.000 million-$390.000 million vs $383.864 million estimate.